Clearside Biomedical Inc Cash Flow Quality Index
Clearside Biomedical Inc cash flow quality index. Clearside Biomedical Inc (CLSD) has a Cash Flow Quality Index of 0.27x as of December 2021. Operating cash flow of $5.05 Million is below net income of $18.71 Million, suggesting accrual-heavy earnings not yet converted to cash. See CLSD financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Clearside Biomedical Inc (2021–2021)
Cash flow quality index of Clearside Biomedical Inc from 2021 to 2021. Historical Cash Flow Quality Index for Clearside Biomedical Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Clearside Biomedical Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Clearside Biomedical Inc Cash Flow Quality Index by Year (2021–2021)
Clearside Biomedical Inc cash flow quality index by year from 2021 to 2021. Year-by-year earnings quality comparison for Clearside Biomedical Inc. For the full cash flow conversion analysis, see Clearside Biomedical Inc cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -28.55x | $-10.73 Million | $376.00K | — |